By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today said that it has acquired Bioline, a manufacturer and distributor of molecular biology reagents, for $23.3 million in cash on hand.

The acquisition pushes the Cincinnati-based diagnostics firm further into the molecular biology research products and molecular diagnostics fields. It also will provide products to complement the portfolio of its life science business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.